Chronic respiratory failure is a progressive condition in which the respiratory system fails to maintain adequate gas exchange, leading to persistent hypoxemia, hypercapnia, or both. It often develops secondary to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, neuromuscular disorders, or chest wall deformities. Patients may experience exertional or resting shortness of breath, fatigue, morning headaches, sleep disturbances, and diminished exercise tolerance. Unlike acute respiratory failure, chronic forms develop gradually, allowing partial physiological adaptation, but they still significantly impair quality of life and increase susceptibility to infections and cardiovascular complications. Early recognition through clinical assessment, arterial blood gas analysis, and pulmonary function testing is crucial to guide management and prevent disease progression.
Management of chronic respiratory failure requires a comprehensive, individualized approach. Oxygen therapy is prescribed to correct hypoxemia, while non-invasive ventilation supports breathing in patients with hypercapnia or muscle weakness. Pharmacologic therapies targeting underlying lung disease, along with pulmonary rehabilitation, help optimize lung function and endurance. Regular monitoring of arterial blood gases and periodic reassessment of pulmonary mechanics allow timely adjustment of therapy. Nutritional support, vaccination, and infection prevention strategies are essential adjuncts. Multidisciplinary care involving pulmonologists, respiratory therapists, and nutritionists ensures holistic support. Patient education regarding symptom recognition, adherence to therapy, and lifestyle modifications empowers individuals to actively manage their condition. With proactive interventions, patients with chronic respiratory failure can achieve improved functional capacity, reduced hospitalizations, and enhanced overall quality of life.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation